| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.888398 |
| 003 | CaOODSP |
| 005 | 20221107171959 |
| 006 | m o d f |
| 007 | cr ||||||||||| |
| 008 | 200619e202004##onc o f000 0 eng d |
| 020 | |a9780660352879 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aH13-9/5-2020E-PDF |
| 245 | 00|aGuidance document : |bmanagement of disinfectant drug applications. |
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |cApril 2020. |
| 264 | 4|c©2020 |
| 300 | |a1 online resource (iv, 19 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aIssued also in French under title: Ligne directrice : gestion des présentations de désinfectants assimilés aux drogues (2020). |
| 500 | |a"Date adopted: 2018/01; revised date: 2019/12; effective date: 2020/04." |
| 520 | |a"This guidance document provides an overview of the application streams applicable to disinfectant drugs, including disinfectant-sanitizers"--Introduction, page 1. |
| 650 | 0|aDisinfection and disinfectants|xCanada. |
| 650 | 0|aDrug approval|zCanada. |
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
| 775 | 08|tLigne directrice : |w(CaOODSP)9.888399 |
| 795 | |tGuidance document |w(CaOODSP)9.851101 |
| 856 | 40|qPDF|s1.43 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H13-9-5-2020-eng.pdf |